DuPont de Nemours, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DD research report →
Range $53 – $172
Price Chart
About the company
DuPont de Nemours, Inc. is a global provider of advanced materials and innovative solutions, serving markets across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. The company's operations are organized into three primary segments: Electronics & Industrial, Mobility & Materials, and Water & Protection.
- CEO
- Lori D. Koch
- IPO
- 1972
- Employees
- 15,000
- HQ
- Wilmington, DE, US
AI snapshot
Six angles, distilled from the data.
The stock is in a constructive uptrend, trading above both the 50-day and 200-day moving averages, which keeps the intermediate and long-term regime positive. It sits well below the 52-week high of 159.48 but far above the 52-week low of 109.23, suggesting a mature advance rather than a breakout chase.
Street sentiment is constructive, with a Buy consensus and an average target of 172.47 versus the current share price. Recent moves have been mixed but still supportive: Wells Fargo lifted its target to 170, Barclays initiated at Overweight, while RBC and UBS trimmed targets without turning negative.
The earnings cadence is strong, with 8 straight EPS beats and the latest quarter topping estimates by 12.4%. Next-year EPS estimates point materially higher to 7.46 from a 2.87 TTM base, so shareholders should watch whether margin discipline and demand can support that step-up.
Recent insider activity leans to net selling, but much of the tape is mechanical rather than discretionary. The clearest signals are sales by the CEO and General Counsel, while several large M-exempt entries and a director gift look like compensation or transfer-related noise rather than conviction buying.
Profitability is solid but not stretched: gross margin is 35.5%, operating margin 14.39%, and net margin 4.26%. Growth is improving, with revenue up 4.1% year over year and earnings up 149.6%, while free cash flow reached $1.745 billion in 2025.
DuPont’s edge is in specialty chemicals with diversified exposure across healthcare, water, and industrial end markets, which supports steadier earnings than more cyclical peers. On valuation, it trades at 29.51x earnings, a premium setup that needs continued execution to justify.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.27B
- P/E
- 66.64
- Fwd P/E
- 19.49
- PEG
- 0.02
- P/S
- 2.81
- P/B
- 1.48
- EV/EBITDA
- 16.48
- Div Yield
- 1.60%
- Gross Margin
- 34.49%
- Op Margin
- 13.38%
- Net Margin
- 4.26%
- ROE
- 2.18%
- ROIC
- 3.08%
Latest fiscal year · YoY change
- Revenue
- $6.85B-44.7%
- Gross Profit
- $2.07B-47.0%
- Op Income
- $860.00M
- Net Income
- $-779,000,000-210.8%
- EPS
- $-5.61-211.3%
- OCF Growth
- -23.6%
- FCF Growth
- -14.9%
- 52W High
- $159.48
- 52W Low
- $111.75
- 50D MA
- $137.01
- 200D MA
- $139.71
- Beta
- 1.08
- RSI (14)
- 51
- Avg Volume
- 1.10M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
DuPont delivered another quarter ahead of guidance, with 5% organic growth, 90 bps margin expansion, and a higher full-year outlook, while continuing aggressive buybacks and productivity gains.· November 3, 2026
- Q3 sales were $1.9 billion, up 4% year over year on 5% organic growth; operating EBITDA was $469 million, up 8%, with margin up 90 bps to 25.1%.
- Adjusted EPS rose 31% to $2.09; transaction-adjusted free cash flow was $341 million with 121% conversion, and full-year conversion is now expected to be about 100% versus a 90% target.
- Full-year 2026 guidance was raised: organic sales growth now ~4.5%, sales about $7.19 billion, operating EBITDA $1.785 billion, and adjusted EPS midpoint $7.50.
- Management said productivity was a major driver, with over 2% net productivity in the quarter and a target of net 3% COGS productivity over time.
- Capital returns remain active: DuPont completed a $250 million ASR, substantially completed another $100 million of open-market buybacks, and plans another $250 million repurchase in Q4.
DuPont reported Q3 net sales of $1.9 billion, up 4% year over year, with 5% organic sales growth and a 1% currency headwind. Operating EBITDA was $469 million, up 8% year over year, and operating EBITDA margin was 25.1%, up 90 basis points. Adjusted EPS was $2.09, up 31% year over year. Transaction-adjusted free cash flow was $341 million, with 121% conversion. For full-year 2026, management raised guidance to approximately 4.5% organic growth, about $7.19 billion in sales, $1.785 billion of operating EBITDA, and adjusted EPS of $7.50 at the midpoint. Fourth-quarter guidance calls for about $1.825 billion of sales, $455 million of operating EBITDA, and adjusted EPS of $1.90 to $1.95; management also said about $15 million of Middle East water revenue was pushed into 2027.
Lori Koch framed the quarter as evidence that DuPont’s portfolio and execution are working, pointing to broad-based sales growth, margin expansion, and stronger cash generation. She emphasized that the company is still early in its productivity and innovation initiatives, but already seeing measurable benefits from better quality, delivery, procurement, AI tools, and a more disciplined innovation process. Her tone was upbeat and confident, especially on DuPont’s ability to enter 2027 with momentum and to keep compounding earnings and shareholder returns.
Antonella Franzen focused on the bridge from growth and productivity to stronger margins and cash. She cited 5% organic growth, $469 million of operating EBITDA, 25.1% margin, $341 million of transaction-adjusted free cash flow, and 121% conversion, and said full-year free cash flow conversion is now expected to be about 100%. On capital allocation, she highlighted a strong cash position, net debt-to-EBITDA of 1.1x, and the flexibility to balance buybacks with M&A; she also said pricing for the full year is now closer to $110 million versus the previously discussed $90 million.
Analysts pressed for detail on the margin drivers, and management said more than 2% net productivity in the quarter drove about 100 bps of EBITDA margin lift, with additional benefit from volume, procurement savings, and better OTIF. Several questions focused on the Middle East water projects, and management quantified the 2026 pushout at about $15 million. Analysts also asked about buybacks versus M&A, and management said repurchases are opportunistic rather than automatic because the company still sees a robust bolt-on pipeline and wants to preserve flexibility for accretive deals.
The bull case from this call is that DuPont is delivering growth and margin expansion despite a mixed macro backdrop, with strength in healthcare, aerospace, EV battery applications, and water markets excluding the Middle East. Management sounded confident that productivity, pricing, and AI-enabled operating improvements can keep compounding results, while cash generation and balance-sheet flexibility support both buybacks and potential M&A.
The main risks flagged on the call were continued disruptions in the Middle East water business, which management said pushed about $15 million into 2027, and broader end-market softness in parts of construction and automotive. Management also noted oil and gas inflation, exposure to price moves in raw materials, and that some margin gains are being offset by growth investments, suggesting execution remains important to sustaining the current pace.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.5%
- Shares Outstanding
- 132.53M
- Float Shares
- 131.92M
of shares held by institutions
1,166 13F filers
Buy/sell ratio 2.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for DD, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Sell | Sep 4, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Jul 17, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jan 9, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Nov 12, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Aug 4, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | May 15, 25 | Filing → |
| Jefferson ShreveHouse · IN06 | Sell | Mar 31, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Feb 23, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 10, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 10, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Nov 3, 23 | Filing → |
| Lois FrankelHouse · FL22 | Sell | Sep 8, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 50.79M | ▼ 80.21K |
| Blackrock, Inc. | 10.53M | ▼ 109.94K |
| Vanguard Capital Management LLC | 8.84M | ▼ 98.51K |
| State Street Corp | 6.15M | ▼ 799.35K |
| Vanguard Portfolio Management LLC | 6.07M | ▼ 339.74K |
| Invesco Ltd. | 3.97M | ▲ 181.88K |
| Geode Capital Management, LLC | 3.75M | ▲ 5.96K |
| Morgan Stanley | 2.71M | ▼ 7.41K |
| Victory Capital Management Inc | 2.70M | ▲ 342.73K |
| Northern Trust Corp | 1.81M | ▲ 210.51K |
| Jpmorgan Chase & Co | 1.72M | ▲ 203.44K |
| Goldman Sachs Group Inc | 1.68M | ▼ 375.29K |
Held by 1,544 ETFs
Biggest fund positions in DD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 26 | BREEN EDWARD D | other | 18,945 |
| Nov 9, 26 | Hoover Erik T. | other | 4,203 |
| Nov 9, 26 | Hoover Erik T. | sell | 4,203 |
| Nov 9, 26 | Hoover Erik T. | other | 4,203 |
| Nov 9, 26 | Koch Lori | other | 2,311 |
| Nov 9, 26 | Koch Lori | sell | 2,311 |
| Nov 9, 26 | Koch Lori | other | 2,311 |
| Nov 5, 26 | BREEN EDWARD D | other | 89,845 |
| Aug 28, 26 | BREEN EDWARD D | other | 35,551 |
| Nov 5, 26 | BREEN EDWARD D | sell | 89,845 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DD coverage
Recent articles, reports, and earnings notes.

DuPont de Nemours (DD): Margin Expansion and EPS Momentum
DuPont posted 5.0% organic growth, 31% adjusted EPS growth, and stronger margins in Q3 2026, while raising full-year guidance. Valuation is reasonable on forward earnings, but execution and cyclical end-market risks remain.

DuPont de Nemours, Inc. (DD) rises on earnings beat
DuPont de Nemours, Inc. (DD) rises after reporting third-quarter results that topped estimates and lifting full-year guidance again. Stronger sales, higher adjusted EPS, and robust cash flow fueled the rally, while buybacks added support. The stock now trades near its 52-week high, raising the bar for new buyers.

Koch Industries Isn’t Public. Here’s How to Get Exposure Anyway
No, Koch Industries is not publicly traded. Retail investors can’t buy Koch stock directly, so the practical options are public peers, waiting for an IPO that does not appear to be in motion, or limited accredited-only private secondary markets.
Want a deeper read on DD?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
DuPont Advances Water Treatment With First U.S. OxyMem Installation
zacks.com · Nov 18
duPont REGISTRY Group Celebrates First Anniversary of duPont REGISTRY Live
businesswire.com · Nov 17
DuPont announces first OxyMem™ MABR installation in the United States
prnewswire.com · Nov 17
DuPont de Nemours, Inc. $DD Position Trimmed by Aberdeen Group plc
defenseworld.net · Nov 17
Wolters Kluwer Announces DuPont as Winner of 2026 Legal Innovator Award
businesswire.com · Nov 13
DuPont Announces Collaboration with Microsoft and NobleAI to Accelerate R&D Innovation with AI
prnewswire.com · Nov 12
3 Diversified Chemical Stocks to Watch Amid Industry Headwinds
zacks.com · Nov 11
DuPont Expands High-Purity Water Solutions With New EDI Modules
zacks.com · Nov 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 18, 2026 · Live quote · Not investment advice